Evaluation of Immunogenicity and Clinical Protection of SARS-CoV-2 S1 and N Antigens in Syrian Golden Hamster

Evaluation of Immunogenicity and Clinical Protection of SARS-CoV-2 S1 and N Antigens in Syrian Golden Hamster

The novel coronavirus (SARS-CoV-2) epidemic continues to be a global public crisis affecting human health. Many research groups are developing different types of vaccines to suppress the spread of SARS-CoV-2, and some vaccines have entered phase III clinical trials and have been rapidly implemented....

Full description

Bibliographic Details
Main Authors: Zhenye Niu, Xueqi Li, Yang Gao, Lichun Wang, Shengtao Fan, Xingli Xu, Guorun Jiang, Pingfang Cui, Dandan Li, Yun Liao, Li Yu, Heng Zhao, Ying Zhang, Qihan Li
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Vaccines
Subjects:
spike protein
nucleocapsid protein
polypeptide vaccine
Syrian golden hamster
Online Access:https://www.mdpi.com/2076-393X/10/12/1996

Internet

https://www.mdpi.com/2076-393X/10/12/1996

Similar Items